TrialClinical immunology (Orlando, Fla.)2014

Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.

Jonathan L Berkowitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.